| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.4 | 7e-10 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 9e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |